InMed Stock Volatility Indicators True Range

INM
 Stock
  

USD 2.62  0.12  4.38%   

InMed Pharmaceuticals volatility indicators tool provides the execution environment for running the True Range indicator and other technical functions against InMed Pharmaceuticals. InMed Pharmaceuticals value trend is the prevailing direction of the price over some defined period of time. The concept of trend is an important idea in technical analysis, including the analysis of volatility indicators indicators. As with most other technical indicators, the True Range indicator function is designed to identify and follow existing trends. InMed Pharmaceuticals volatility indicators enable investors to predict price movements based on how different True Range indicators change over time.

Indicator
The output start index for this execution was one with a total number of output elements of sixty. The True Range is a measure of InMed Pharmaceuticals volatility developed by Welles Wilder.
.

InMed Pharmaceuticals Technical Analysis Modules

Most technical analysis of InMed Pharmaceuticals help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for InMed from various momentum indicators to cycle indicators. When you analyze InMed charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About InMed Pharmaceuticals Predictive Technical Analysis

Predictive technical analysis modules help investors to analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of InMed Pharmaceuticals. We use our internally-developed statistical techniques to arrive at the intrinsic value of InMed Pharmaceuticals based on widely used predictive technical indicators. In general, we focus on analyzing InMed Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build InMed Pharmaceuticals's daily price indicators and compare them against related drivers, such as volatility indicators and various other types of predictive indicators. Using this methodology combined with a more conventional technical analysis and fundamental analysis, we attempt to find the most accurate representation of InMed Pharmaceuticals's intrinsic value. In addition to deriving basic predictive indicators for InMed Pharmaceuticals, we also check how macroeconomic factors affect InMed Pharmaceuticals price patterns. Please read more on our technical analysis page or use our predictive modules below to complement your research.
 2019 2020 2021 2022 (projected)
Current Ratio3.773.783.44.52
Book Value per Share28.1527.4424.730.43
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of InMed Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of InMed Pharmaceuticals in the context of predictive analytics.
Hype
Prediction
LowEstimated ValueHigh
0.132.5717.07
Details
Intrinsic
Valuation
LowReal ValueHigh
0.183.6218.12
Details
2 Analysts
Consensus
LowTarget PriceHigh
6.006.757.50
Details
Earnings
Estimates (3)
LowProjected EPSHigh
-1-0.93-0.87
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as InMed Pharmaceuticals. Your research has to be compared to or analyzed against InMed Pharmaceuticals' peers to derive any actionable benefits. When done correctly, InMed Pharmaceuticals' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in InMed Pharmaceuticals.

Learn to be your own money manager

As an individual investor, you need to find a reliable way to track all your investment portfolios' performance accurately. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing you full analytical transparency into your positions, our tools can tell you how much better you can do without increasing your risk or reducing expected return.

Did you try this?

Run Commodity Channel Index Now

   

Commodity Channel Index

Use Commodity Channel Index to analyze current equity momentum
All  Next Launch Module

InMed Pharmaceuticals pair trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if InMed Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in InMed Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.

InMed Pharmaceuticals Pair Trading

InMed Pharmaceuticals Pair Trading Analysis

The ability to find closely correlated positions to InMed Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace InMed Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back InMed Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling InMed Pharmaceuticals to buy it.
The correlation of InMed Pharmaceuticals is a statistical measure of how it moves in relation to other equities. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as InMed Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if InMed Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for InMed Pharmaceuticals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Please see Risk vs Return Analysis. You can also try Transaction History module to view history of all your transactions and understand their impact on performance.

Complementary Tools for analysis

When running InMed Pharmaceuticals price analysis, check to measure InMed Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy InMed Pharmaceuticals is operating at the current time. Most of InMed Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of InMed Pharmaceuticals' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move InMed Pharmaceuticals' price. Additionally, you may evaluate how the addition of InMed Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Go
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Go
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Go
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Go
Commodity Channel Index
Use Commodity Channel Index to analyze current equity momentum
Go
Price Transformation
Use Price Transformation models to analyze depth of different equity instruments across global markets
Go
CEO Directory
Screen CEOs from public companies around the world
Go
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Go
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Go
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Go
Is InMed Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of InMed Pharmaceuticals. If investors know InMed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about InMed Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
M
Return On Assets
(0.56) 
Return On Equity
(1.46) 
The market value of InMed Pharmaceuticals is measured differently than its book value, which is the value of InMed that is recorded on the company's balance sheet. Investors also form their own opinion of InMed Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is InMed Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because InMed Pharmaceuticals' market value can be influenced by many factors that don't directly affect InMed Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between InMed Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine InMed Pharmaceuticals value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, InMed Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.